<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="98968">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01681758</url>
  </required_header>
  <id_info>
    <org_study_id>AICU2012-007</org_study_id>
    <nct_id>NCT01681758</nct_id>
  </id_info>
  <brief_title>An Assessment of Pulse Pressure Variation to Guide Fluid Therapy in Cardiac Surgery Patients</brief_title>
  <official_title>A Before-and-after Assessment of Pulse Pressure Variation Guided Fluid Therapy in Cardiac Surgery Patients Receiving Mandatory Mechanical Ventilation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Austin Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Austin Health</source>
  <oversight_info>
    <authority>Australia: Human Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      We aim to test the hypothesis that fluid therapy based on pulse pressure variation (PPV) in
      patients after cardiac surgery who are mechanically ventilated leads to a significant
      decrease in the amount of fluid given to such patients in the first 24 hours after surgery
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. The investigators will study patients after cardiac surgery

        2. The investigators will collect data on standard care in pre-intervention population

        3. The investigators will collect demographic and clinical data

        4. The investigators will collect biochemical data in the first 24 hours after surgery

        5. The investigators will collect biochemical, physiological and clinical outcome data

        6. The investigators will compare the standard care and intervention period data
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2012</start_date>
  <completion_date type="Actual">April 2013</completion_date>
  <primary_completion_date type="Actual">April 2013</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Mean amount of fluid given in the first 24 hours after surgery</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>all intravenous fluid administered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Physiological outcome</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Blood lactate</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physiological outcome</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>cardiac index</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>PPV</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>use PPV to guide fluid therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>standard care</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>fluids according to standard care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>IV fluid according to PPV</intervention_name>
    <description>intravenous fluids</description>
    <arm_group_label>PPV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>fluids according to standard care</intervention_name>
    <arm_group_label>standard care</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. immediately after ICU admission after cardiac surgery

          2. mandatory mechanical ventilation -

        Exclusion Criteria:

          1. Pressure support ventilation

          2. ECMO

          3. Intra-aortic balloon counterpulsation
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Austin Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3079</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 9, 2013</lastchanged_date>
  <firstreceived_date>September 6, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Austin Health</investigator_affiliation>
    <investigator_full_name>Rinaldo Bellomo</investigator_full_name>
    <investigator_title>Director of ICU Research</investigator_title>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>Pulse pressure variation</keyword>
  <keyword>intravenous fluids</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
